| Price | +/- | % +/- | Bid | Offer | Volume | High | Low | Last close |
|---|---|---|---|---|---|---|---|---|
| 1,219.50 | +0.50 | +0.04% | 1,219.00 | 1,220.00 | 8,031,099 | 1,227.05 | 1,217.12 | 1,219.00 on 08-Feb-2010 |
| Time/Date | Price | Volume | Trade value | Type |
|---|---|---|---|---|
| 14:41:22 | 1,219.50 | 13 | 158.54 | AT |
| 14:41:13 | 1,219.88 | 278 | 3,391.25 | O |
| 14:41:20 | 1,219.50 | 16 | 195.12 | AT |
| 14:41:19 | 1,219.50 | 468 | 5,707.26 | AT |
| 14:41:19 | 1,219.50 | 316 | 3,853.62 | AT |
| 09-Feb-2010 | |
|---|---|
| FTSE index | FTSE All-Share,FTSE Eurotop 300,FTSE 350 High Yield,FTSE 100,FTSE 350 (ex IT),FTSE techMARK All-Share,FTSE All-Share (ex IT),FTSE 350 |
| FTSE sector | Pharmaceuticals & Biotechnology |
| FTSE sub-sector | Pharmaceuticals |
| Country of share register | GB |
| Segment | SET0 |
| MiFID Status | |
| Exchange market size | 4,000 |
| SEDOL | 0925288 |
| ISIN number | GB0009252882 |
| 2009 (£m) | 2008 (£m) | 2007 (£m) | 2006 (£m) | |
|---|---|---|---|---|
| Currency | GBP | GBP | GBP | GBP |
| Total op. expenses | -21,078.00 | -17,752.00 | -15,598.00 | -15,724.00 |
| P/L for the financial year | 5,531.00 | 4,602.00 | 5,214.00 | 5,389.00 |
| Retained profit/loss | 2,528.00 | 1,673.00 | 2,421.00 | 2,791.00 |
| Total assets | 42,862.00 | 39,393.00 | 31,003.00 | 25,553.00 |
| Total liabilities | -42,862.00 | -39,393.00 | -31,003.00 | -25,553.00 |
| Time/Date | Headline |
|---|---|
| 12:03 09-Feb-10 | Director/PDMR Shareholding |
| 17:27 05-Feb-10 | Director/PDMR Shareholding |
| 16:32 05-Feb-10 | Director/PDMR Shareholding |
| 16:27 04-Feb-10 | GSK amends emerging market data in 2009 results |
| 12:00 04-Feb-10 | Final Results |